Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
University of Colorado Cancer Center
mi
from
Aurora, CO
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Christiana Care Health System
mi
from
Newark, DE
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Christiana Care Health System
mi
from
Newark, DE
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Emory University School of Medicine
mi
from
Atlanta, GA
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
University of Chicago Medical Center
mi
from
Chicago, IL
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
NIH/National Cancer Institute
mi
from
Bethesda, MD
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
NIH/National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Columbia University Medical Center
mi
from
New York, NY
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
Princess Margaret Hospital
mi
from
Toronto,
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
Princess Margaret Hospital
mi
from
Toronto,
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Ironwood Cancer and Research Center
mi
from
Chandler, AZ
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Ironwood Cancer and Research Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Arizona Center for Hematology Oncology
mi
from
Glendale, AZ
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Arizona Center for Hematology Oncology
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Providence Health System
mi
from
Beverly Hills, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Providence Health System
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Cancer Care Associates of Fresno Medical Group Inc
mi
from
Fresno, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Cancer Care Associates of Fresno Medical Group Inc
mi
from
Fresno, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Medical Oncology Hematology
mi
from
Gilroy, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Medical Oncology Hematology
mi
from
Gilroy, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
California Cancer Care
mi
from
Greenbrae, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
California Cancer Care
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Wilshire Medical Oncology Group
mi
from
La Verne, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Wilshire Medical Oncology Group
mi
from
La Verne, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Glendale Adventist Medical Center
mi
from
Los Angeles, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Glendale Adventist Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Clinical Trials and Research Associates, Inc.
mi
from
Montebello, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Clinical Trials and Research Associates, Inc.
mi
from
Montebello, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
North Country Oncology-Hematology
mi
from
Oceanside, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
North Country Oncology-Hematology
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Pacific Hematology Oncology Associates
mi
from
San Francisco, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Pacific Hematology Oncology Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Central Coast Medical Oncology
mi
from
Santa Maria, CA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Central Coast Medical Oncology
mi
from
Santa Maria, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Rocky Mountain Cancer Centers, LLP
mi
from
Denver, CO
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Rocky Mountain Cancer Centers, LLP
mi
from
Denver, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Hematology Oncology Associates, PC
mi
from
Stamford, CT
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Hematology Oncology Associates, PC
mi
from
Stamford, CT
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Center for Hematology Oncology
mi
from
Boca Raton, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Center for Hematology Oncology
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Medical Specialists of the Palm Beaches
mi
from
Deerfield Beach, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Medical Specialists of the Palm Beaches
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Cancer Care of North Florida, P.A.
mi
from
Lake City, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Cancer Care of North Florida, P.A.
mi
from
Lake City, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Florida Cancer Institute- New Hope
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Ocala Oncology Center Pl
mi
from
Ocala, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Ocala Oncology Center Pl
mi
from
Ocala, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
University Hematology Oncology, Inc
mi
from
Centralia, IL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
University Hematology Oncology, Inc
mi
from
Centralia, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
University of Chicago Medical Center
mi
from
Chicago, IL
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Deaconess Clinic Downtown
mi
from
Evansville, IN
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Deaconess Clinic Downtown
mi
from
Evansville, IN
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Community Hospital
mi
from
Munster, IN
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Community Hospital
mi
from
Munster, IN
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Kentucky Cancer Center
mi
from
Hazard, KY
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Kentucky Cancer Center
mi
from
Hazard, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Baptist Health System, Inc.
mi
from
Lexington, KY
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Baptist Health System, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center
mi
from
Alexandria, LA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Christus Saint Frances, Cabrini Hospital, Cabrini Cancer Center
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Hematology and Oncology Specialists
mi
from
Metairie, LA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Hematology and Oncology Specialists
mi
from
Metairie, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
National Cancer Institute
mi
from
Bethesda, MD
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Maryland Oncology Hematology PA
mi
from
Columbia, MD
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Maryland Oncology Hematology PA
mi
from
Columbia, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Berkshire Hematology Oncology, PC
mi
from
Pittsfield, MA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Berkshire Hematology Oncology, PC
mi
from
Pittsfield, MA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Detroit Clinical Research Center PC
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Queens Hospital Center
mi
from
Jamaica, NY
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Queens Hospital Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Syracuse Veterns Affairs Medical Center
mi
from
Syracuse, NY
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Syracuse Veterns Affairs Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Willamette Valley Cancer Institute/Research Ctr
mi
from
Eugene, OR
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
St. Luke's Cancer Center Associates
mi
from
Bethlehem, PA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
St. Luke's Cancer Center Associates
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Gettysburg Cancer Center
mi
from
Gettysburg, PA
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Gettysburg Cancer Center
mi
from
Gettysburg, PA
Click here to add this to my saved trials
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated:  11/13/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
A Randomized, Double-Blind, Placebo-Controlled, Study of the Safety and Efficacy of Farletuzumab in Combination With a Platinum Containing Doublet in Chemotherapy-Naїve Subjects With Stage IV Adenocarcinoma of the Lung
Status: Enrolling
Updated: 11/13/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials